• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Hyderabad , Jan. 17

Krebs Biochemicals & Industries Ltd has decided to issue 10.5 lakh equity shares on a preferential basis to Ranbaxy Laboratories Ltd at a price of Rs 85 per share (including Rs 10 nominal value and Rs 75 premium).

The company has informed the BSE that the board of directors, at its meeting held on January 15, approved the proposal.

More Stories on : Preferential Allotments | Bio-tech & Genetics | Ranbaxy Laboratories Ltd

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Bolero, Scorpio prices hiked

Copyright © 2007, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line